Anita Dushyanth
Stock Analyst at Berenberg
(2.60)
# 1,991
Out of 5,182 analysts
4
Total ratings
75%
Success rate
15.74%
Average return
Main Sectors:
Stocks Rated by Anita Dushyanth
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| URGN UroGen Pharma | Initiates: Buy | $20 | $18.03 | +10.93% | 1 | Apr 27, 2022 | |
| SERA Sera Prognostics | Initiates: Buy | $13 | $2.16 | +501.85% | 1 | Apr 27, 2022 | |
| BTAI BioXcel Therapeutics | Initiates: Buy | $1,200 | $1.09 | +109,991.74% | 1 | Apr 9, 2021 | |
| PCRX Pacira BioSciences | Initiates: Buy | $93 | $22.53 | +312.78% | 1 | Apr 9, 2021 |
UroGen Pharma
Apr 27, 2022
Initiates: Buy
Price Target: $20
Current: $18.03
Upside: +10.93%
Sera Prognostics
Apr 27, 2022
Initiates: Buy
Price Target: $13
Current: $2.16
Upside: +501.85%
BioXcel Therapeutics
Apr 9, 2021
Initiates: Buy
Price Target: $1,200
Current: $1.09
Upside: +109,991.74%
Pacira BioSciences
Apr 9, 2021
Initiates: Buy
Price Target: $93
Current: $22.53
Upside: +312.78%